Assessment of acceptability and usability of new delivery prototype device for intradermal vaccination in healthy subjects.

The new VAX-ID prototype device was shown to have a high degree of acceptability as well as usability. Further studies with VAX-ID will be conducted using vaccine antigen allowing assessment of immunogenicity and safety. Additionally, these studies will help to further improve VAX-ID in terms of accuracy of delivered dose and feedback to the vaccinator. (NCT01963338).

Van Mulder TJ., Verwulgen S., Beyers KC., Scheelen L., Elseviers MM., Van Damme P., Vankerckhoven V.

Human Vaccines & Immunotherapeurics, 2014, 10 (12), 3746-3753.
doi: 10.4161/21645515.2014.979655

To read more about the publication, click here.